{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:16:24Z","timestamp":1771935384779,"version":"3.50.1"},"reference-count":45,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2017.0255","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:29:13Z","timestamp":1525253353000},"source":"Crossref","is-referenced-by-count":8,"title":["Risk of Intussusception After Rotavirus Vaccination"],"prefix":"10.3238","author":[{"given":"Judith","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Harder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"von Kries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2017,4,14]]},"reference":[{"key":"10.3238\/arztebl.2017.0255_ref1","doi-asserted-by":"crossref","unstructured":"Parashar UD, Gibson CJ, Bresee JS, Glass RI: Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12: 304\u20136","DOI":"10.3201\/eid1202.050006"},{"key":"10.3238\/arztebl.2017.0255_ref2","doi-asserted-by":"crossref","unstructured":"Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD: 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 136\u201341","DOI":"10.1016\/S1473-3099(11)70253-5"},{"key":"10.3238\/arztebl.2017.0255_ref3","doi-asserted-by":"crossref","unstructured":"Koch J, Wiese-Posselt M: Epidemiology of rotavirus infections in children less than 5 years of age: Germany, 2001\u20132008. Pediatr Infect Dis J 2011; 30: 112\u20137","DOI":"10.1097\/INF.0b013e3181f1eb21"},{"key":"10.3238\/arztebl.2017.0255_ref4","doi-asserted-by":"crossref","unstructured":"Rieck T, Feig M, Eckmanns T, et al.: Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother; 10: 476\u201384","DOI":"10.4161\/hv.26986"},{"key":"10.3238\/arztebl.2017.0255_ref5","unstructured":"European Medicines Agency: Rotarix. Scientific discussion, 11 September 2006. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/human\/000639\/WC500054589.pdf (last accessed on 29 March 2017)."},{"key":"10.3238\/arztebl.2017.0255_ref6","unstructured":"European Medicines Agency: RotaTeq. Scientific discussion, 21 September 2006. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/human\/000669\/WC500054183.pdf (last accessed on 9 January 2017)."},{"key":"10.3238\/arztebl.2017.0255_ref7","doi-asserted-by":"crossref","unstructured":"Bines JE, Liem NT, Justice FA, et al.: Risk factors for intussusception in infants in Vietnam and Australia: adenovirus implicated, but not rotavirus. J Pediatr 2006; 149: 452\u201360","DOI":"10.1016\/j.jpeds.2006.04.010"},{"key":"10.3238\/arztebl.2017.0255_ref8","doi-asserted-by":"crossref","unstructured":"Wei\u00df S, Streng A, Kries RV, Liese J, Wirth S, Jenke AC: Inzidenz der Invagination bei S\u00e4uglingen in Deutschland. Eine Sch\u00e4tzung anhand der Capture-Recapture-Methode. Klinische P\u00e4diatrie 2011; 223: 419\u201323","DOI":"10.1055\/s-0031-1279735"},{"key":"10.3238\/arztebl.2017.0255_ref9","doi-asserted-by":"crossref","unstructured":"Kramarz P, France EK, Destefano F, et al.: Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 2001; 20: 410\u20136 CrossRef","DOI":"10.1097\/00006454-200104000-00008"},{"key":"10.3238\/arztebl.2017.0255_ref10","unstructured":"Centers for Disease Control and Prevention (CDC): Intussusception among recipients of rotavirus vaccine, United States, 1998\u20131999. Morb Mortal Wkly Rep (MMWR) 1999; 48: 577\u201381"},{"key":"10.3238\/arztebl.2017.0255_ref11","doi-asserted-by":"crossref","unstructured":"Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al.: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11\u201322","DOI":"10.1056\/NEJMoa052434"},{"key":"10.3238\/arztebl.2017.0255_ref12","doi-asserted-by":"crossref","unstructured":"Vesikari T, Matson DO, Dennehy P, et al.: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23\u201333","DOI":"10.1056\/NEJMoa052664"},{"key":"10.3238\/arztebl.2017.0255_ref13","doi-asserted-by":"crossref","unstructured":"Belongia EA, Irving SA, Shui IM, et al.: Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 2010; 29: 1\u20135","DOI":"10.1097\/INF.0b013e3181af8605"},{"key":"10.3238\/arztebl.2017.0255_ref14","doi-asserted-by":"crossref","unstructured":"Shui IM, Baggs J, Patel M, et al.: Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012; 307: 598\u2013604","DOI":"10.1001\/jama.2012.97"},{"key":"10.3238\/arztebl.2017.0255_ref15","unstructured":"Centers for Disease Control and Prevention (CDC): Postmarketing monitoring of intussusception after RotaTeq (TM) vaccination, United States, February 1, 2006 \u2013 February 15, 2007. Morb Mortal Wkly Rep (MMWR) 2007; 56: 218\u201322"},{"key":"10.3238\/arztebl.2017.0255_ref16","doi-asserted-by":"crossref","unstructured":"Loughlin J, Mast TC, Doherty MC, Wang FT, Wong J, Seeger JD: Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine. Pediatr Infect Dis J 2012; 31: 292\u20136","DOI":"10.1097\/INF.0b013e3182421390"},{"key":"10.3238\/arztebl.2017.0255_ref17","doi-asserted-by":"crossref","unstructured":"Haber P, Patel M, Izurieta HS, et al.: Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008; 121: 1206\u201312","DOI":"10.1542\/peds.2007-3793"},{"key":"10.3238\/arztebl.2017.0255_ref18","doi-asserted-by":"crossref","unstructured":"Patel MM, L\u00f3pez-Collada VR, Bulh\u00f5es MM, et al.: Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364: 2283\u201392","DOI":"10.1056\/NEJMoa1012952"},{"key":"10.3238\/arztebl.2017.0255_ref19","doi-asserted-by":"crossref","unstructured":"Buttery JP, Danchin MH, Lee KJ, et al.: Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29: 3061\u20136","DOI":"10.1016\/j.vaccine.2011.01.088"},{"key":"10.3238\/arztebl.2017.0255_ref20","unstructured":"Australian Government, Department of Health and Ageing, Therapeutic Goods Administration: Rotavirus vaccination and risk of intussusception. www.tga.gov.au\/safety\/alerts-medicine-rotavirus-110225.htm (last accessed on 8 February 2017)."},{"key":"10.3238\/arztebl.2017.0255_ref21","doi-asserted-by":"crossref","unstructured":"Escolano S, Farrington CP, Hill C, Tubert-Bitter P: Intussusception after rotavirus vaccination\u2014spontaneous reports. N Engl J Med 2011; 365: 2139","DOI":"10.1056\/NEJMc1107771"},{"key":"10.3238\/arztebl.2017.0255_ref22","doi-asserted-by":"crossref","unstructured":"Oberle D, Jenke AC, von Kries R, Keller-Stanislawski B: [Rotavirus vaccination: a risk factor for intussusception?] Bundesgesundheitsblatt \u2013 Gesundheitsforschung \u2013 Gesundheitsschutz 2014; 57: 234\u201341","DOI":"10.1007\/s00103-013-1893-0"},{"key":"10.3238\/arztebl.2017.0255_ref23","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535","DOI":"10.1136\/bmj.b2535"},{"key":"10.3238\/arztebl.2017.0255_ref24","doi-asserted-by":"crossref","unstructured":"Bines JE, Kohl KS, Forster J, et al.: Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004; 22: 569\u201374","DOI":"10.1016\/j.vaccine.2003.09.016"},{"key":"10.3238\/arztebl.2017.0255_ref25","doi-asserted-by":"crossref","unstructured":"Weldeselassie YG, Whitaker HJ, Farrington CP: Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect 2011; 139: 1805\u201317","DOI":"10.1017\/S0950268811001531"},{"key":"10.3238\/arztebl.2017.0255_ref26","doi-asserted-by":"crossref","unstructured":"Yung CF, Chan SP, Soh S, Tan A, Thoon KC: Intussusception and monovalent rotavirus vaccination in singapore: selfcontrolled case series and risk-benefit study. J Pediatr 2015; 167: 163\u20138","DOI":"10.1016\/j.jpeds.2015.03.038"},{"key":"10.3238\/arztebl.2017.0255_ref27","doi-asserted-by":"crossref","unstructured":"Escolano S, Hill C, Tubert-Bitter P: Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach. Vaccine 2015; 33: 1017\u201320","DOI":"10.1016\/j.vaccine.2015.01.005"},{"key":"10.3238\/arztebl.2017.0255_ref28","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Vilar S, D\u00edez-Domingo J, Puig-Barber\u00e0 J, Gil-Prieto R, Romio S: Intussusception following rotavirus vaccination in the Valencia region, Spain. Hum Vaccin Immunother 2015; 11: 1848\u201352","DOI":"10.1080\/21645515.2015.1049787"},{"key":"10.3238\/arztebl.2017.0255_ref29","doi-asserted-by":"crossref","unstructured":"Yih WK, Lieu TA, Kulldorff M, et al.: Intussusception risk after rotavirus vaccination in U.S. infants. New Engl J Med 2014; 370: 503\u201312","DOI":"10.1056\/NEJMoa1303164"},{"key":"10.3238\/arztebl.2017.0255_ref30","doi-asserted-by":"crossref","unstructured":"Vel\u00e1zquez FR, Colindres RE, Grajales C, et al.: Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012; 31: 736\u201344","DOI":"10.1097\/INF.0b013e318253add3"},{"key":"10.3238\/arztebl.2017.0255_ref31","doi-asserted-by":"crossref","unstructured":"Haber P, Patel M, Pan Y, et al.: Intussusception after rotavirus vaccines reported to US VAERS, 2006\u20132012. Pediatrics 2013; 131: 1042\u20139","DOI":"10.1542\/peds.2012-2554"},{"key":"10.3238\/arztebl.2017.0255_ref32","doi-asserted-by":"crossref","unstructured":"Haber P, Parashar UD, Haber M, DeStefano F: Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008\u20132014. Vaccine 2015; 33: 4873\u20137","DOI":"10.1016\/j.vaccine.2015.07.054"},{"key":"10.3238\/arztebl.2017.0255_ref33","doi-asserted-by":"crossref","unstructured":"Stowe J, Andrews N, Ladhani S, Miller E: The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation. Vaccine 2016; 34: 3684\u20139","DOI":"10.1016\/j.vaccine.2016.04.050"},{"key":"10.3238\/arztebl.2017.0255_ref34","doi-asserted-by":"crossref","unstructured":"Carlin JB, Macartney KK, Lee KJ, et al.: Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2018s National Immunization Program. CID 2013; 57: 1427\u201334","DOI":"10.1093\/cid\/cit520"},{"key":"10.3238\/arztebl.2017.0255_ref35","doi-asserted-by":"crossref","unstructured":"Ciarlet M, Sani-Grosso R, Yuan G, et al.: Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Pediatr Infect Dis J 2008; 27: 874\u201380","DOI":"10.1097\/INF.0b013e3181782780"},{"key":"10.3238\/arztebl.2017.0255_ref36","unstructured":"Rieck T, Feig M, Wichmann O, Siedler A: Aktuelles aus der KV-Impfsurveillance \u2013 Impfquoten der Rotavirus-, Masern-, HPV- und Influenza-Impfung in Deutschland. Epid Bull 2017; 1: 1\u201312."},{"key":"10.3238\/arztebl.2017.0255_ref37","doi-asserted-by":"crossref","unstructured":"Dudareva-Vizule S, Koch J, An der Heiden M, Oberle D, Keller-Stanislawski B, Wichmann O: Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany. Hum Vaccin Immunother 2012; 8: 1407\u201315","DOI":"10.4161\/hv.21593"},{"key":"10.3238\/arztebl.2017.0255_ref38","doi-asserted-by":"crossref","unstructured":"Gfroerer S, Fiegel H, Rolle U: Invagination. Monatsschrift Kinderheilkunde 2009; 157: 917\u201324","DOI":"10.1007\/s00112-009-2048-0"},{"key":"10.3238\/arztebl.2017.0255_ref39","doi-asserted-by":"crossref","unstructured":"Guyatt G, Oxman AD, Akl EA, et al.: GRADE guidelines: 1. Introduction\u2013GRADE evidence profiles and summary of findings tables. J Clinical Epidemiol 2011; 64: 383\u201394","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"10.3238\/arztebl.2017.0255_ref40","unstructured":"Wood N, Cannings K, Quinn H, et al.: Rotavirus vaccines and intussusception: An increased risk. J Paediatr Child Health 2011; 47 (Suppl 2): 16."},{"key":"10.3238\/arztebl.2017.0255_ref41","unstructured":"Haber P, Patel M, Pan Y, et al.: Monitoring of intussusception after rotavirus vaccines-united states, vaccine adverse event reporting system (VAERS), 2006\u20132012. Abstracts of the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. August 25\u201328, 2013. Montreal, Canada. Pharmacoepidemiol Drug Saf 2013; 22 (Suppl 1): 206."},{"key":"10.3238\/arztebl.2017.0255_ref42","doi-asserted-by":"crossref","unstructured":"Escolano S, Hill C, Tubert-Bitter P: A new self-controlled case series method for analyzing spontaneous reports of adverse events after vaccination. Am J Epidemiol 2013; 178: 1496\u2013504","DOI":"10.1093\/aje\/kwt128"},{"key":"10.3238\/arztebl.2017.0255_ref43","unstructured":"Velazquez FR, Colindres R, Grajales C, et al.: Postmarketing surveillance of intussusception following mass introduction of the human rotavirus vaccine in Mexico: An interim analysis. Acta Paediatr 2010; 99: 92."},{"key":"10.3238\/arztebl.2017.0255_ref44","doi-asserted-by":"crossref","unstructured":"Leino T, Ollgren J, Stromberg N, Elonsalo U: Evaluation of the intussusception risk after pentavalent rotavirus vaccination in Finnish infants. PloS ONE 2016; 11: e0144812","DOI":"10.1371\/journal.pone.0144812"},{"key":"10.3238\/arztebl.2017.0255_ref45","doi-asserted-by":"crossref","unstructured":"Quinn HE, Wood NJ, Cannings KL, et al.: Intussusception after monovalent human rotavirus vaccine in Australia: severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatric Infect Dis J 2014; 33: 959\u201365","DOI":"10.1097\/INF.0000000000000362"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:19:38Z","timestamp":1638872378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,14]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2017.0255","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,14]]}}}